Rani Therapeutics names Michelle Gilson to board as audit committee chair

Reuters2026/08/04 12:01

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Rani Therapeutics named Michelle Gilson to its board, appointing her audit committee chair.
Gilson was most recently CFO of Arcellx, acquired by Gilead in 2026.
Her earlier career included biotechnology equity research roles at major investment banks.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rani Therapeutics Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608040800PRIMZONEFULLFEED9802896) on August 04, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Rani Therapeutics names Michelle Gilson to board as audit committee chair

You may also like

Crypto prices